Compare FRGT & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRGT | SCNI |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | Mexico | Israel |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.6M |
| IPO Year | N/A | N/A |
| Metric | FRGT | SCNI |
|---|---|---|
| Price | $0.60 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.9M | 41.7K |
| Earning Date | 12-11-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $13,263,031.00 | $1,147,000.00 |
| Revenue This Year | $371.03 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.55 |
| Revenue Growth | N/A | ★ 303.87 |
| 52 Week Low | $0.60 | $0.86 |
| 52 Week High | $13.96 | $6.18 |
| Indicator | FRGT | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 34.59 | 55.65 |
| Support Level | $0.64 | $1.14 |
| Resistance Level | $0.83 | $1.30 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 0.04 | 76.16 |
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.